Abstract Illicit drug users are a high-risk population for infection with the human immunodeficiency virus
HIV infection and neurological disorders
According to a recent estimate, approximately 40 million people worldwide are infected with the human immunodeficiency virus (HIV) (Tanne 2006; Buch et al. 2011) . Anti-HIV therapy, commonly known as either highly active antiretroviral therapy (HAART) or combined antiretroviral therapy (cART), has been proven to be extremely successful in controlling viral replication and prolonging the life span of HIVinfected individuals. Unfortunately, HAART is not able to fully restore the health of HIV patients, even in those with a sustained undetectable viral load. Nearly one third of all HIV-infected patients develop neuropathies, collectively known as HIV-associated neurocognitive disorders (HAND) (Heaton et al. 2011; Alfahad and Nath 2013) . Neurocognitive impairment, even in milder forms, impacts on general health, adds financial burdens, and leads to a deterioration in quality of life (Cook et al. 2008; Nath et al. 2001) . Numerous mechanisms have been proposed to explain these neurocognitive disorders, including neurotoxicity and glial cell activation by viral proteins such as gp120 and transactivator of transcription (Tat) , immune activation, oxidative stress, blood brain barrier (BBB) deterioration, immune cell infiltration, and increased proinflammatory cytokines (Nath , 2015 Dohgu et al. 2011; Kaul et al. 2001) . The suboptimal penetration of HAART in the brain permits sustained low levels of viral replication and brain-adaptive HIV evolution, which eventually contributes to the occasional systemic viral blips (Thompson et al. 2004; Dunfee et al. 2006; Lamers et al. 2010; Sturdevant et al. 2015) . Moreover, recently, we have proposed that owing to the lack of any transcriptional inhibitor, HAART regimens are unable to restrict HIV transcription (Sahu et al. 2015) . Consequently, viral proteins are produced unchecked even in the presence of effective HAART (Rychert et al. 2010) . The immune response against HIV virions and their proteins further contributes to the persistent immune activation and the deterioration of the central nervous system (CNS) in HIV patients (Nath et al. 2001 Klein et al. 1993; Mao et al. 1996; Giunta et al. 2006; Bansal et al. 2000; Eisenstein and Hilburger 1998; Peterson et al. 1993; Bagasra and Pomerantz 1993; Nair et al. 2005; Kaul and Lipton 2006) .
CNS is the common target for cocaine and HIV
Injection and non-injection illicit drug use and abuse contribute significantly to HIV infection and transmission (Buch et al. 2011; Alfahad and Nath 2013; . In the United States, HIV infection in drug addicts accounts for one third of new cases of HIV (Buch et al. 2011; Ferris et al. 2008) . Cocaine, one of the most frequent drugs of abuse, has been implicated as a major contributing factor for HIV infection, transmission, and AIDS progression (Larrat and Zierler 1993; Fiala et al. 1998; Webber et al. 1999) . Both cocaine and HIV target the CNS. Besides promoting HIV replication, cocaine primes the cells to become more susceptible for HIV infection (Kim et al. 2013 (Kim et al. , 2015 Roth et al. 2002) . Within a few days of infection, HIV establishes a reservoir in the CNS by infecting different types of brain cells including resident microglial cells and astrocytes, along with visiting macrophages, and lymphocytes (Kim et al. 2013; Roth et al. 2002; Nath and Clements 2011; Napuri et al. 2013; Mantri et al. 2012; Gekker et al. 2006 ). Due to the suboptimal presence of HAART in the brain, it has been proposed that residual viral replication and the presence of viral proteins (e.g., Tat and gp120) in the CNS impair the functioning of different kinds of brain cells, including neurons, which result in the overall deterioration of the immune and nervous system (Nath et al. 2001 Klein et al. 1993; Mao et al. 1996; Giunta et al. 2006; Bansal et al. 2000; Eisenstein and Hilburger 1998; Peterson et al. 1991 Peterson et al. , 1993 Bagasra and Pomerantz 1993; Nair et al. 2005; Kaul and Lipton 2006) . Cocaine further accelerates this deleterious process by promoting HIV replication and enhancing HIV gene expression. Thus, cocaine intake significantly augments HIV-associated neurotoxicity (neuro-AIDS) in HIV patients, which is clinically recognized as HAND (Alfahad and Nath 2013; Nath et al. 2001; Baldwin et al. 1998; Antinori et al. 2007; Hauser et al. 2006) . Despite the success of HAART in controlling circulating HIV, HAND remains a significant comorbidity responsible for deterioration in quality of life and enhanced mortality of HIV-infected patients (Alfahad and Nath 2013; Nath et al. 2001; Pandya et al. 2005) . Poor adherence to HAART treatment by cocaine users further contributes to HIV disease progression (Robison et al. 2008; Arnsten et al. 2002; Wood et al. 2003) . It is noteworthy that cocaine-using HIV patients, despite adherence to HAART, frequently have higher viral loads and exhibit faster viral rebound following HAART interruption, further indicating that besides promoting HIV replication, cocaine enhances the susceptibility of cells to HIV (Carrico et al. 2007; Carrico 2011; Moore et al. 2004 ). Thus, illicit-drug-using HIV patients are more prone to the HIV-associated comorbidities. Furthermore, the direct correlation of cocaine use with enhanced HIV replications has been well documented by several investigations using HIV-infected humanized mouse models (Roth et al. 2002 (Roth et al. , 2005 Kim et al. 2015) . Hence, drug addiction extraordinarily contributes to the health and financial burden on HIV patients and the society as a whole (Cook et al. 2008; Nath et al. 2001) .
HIV transcription
HIV replication primarily relies on efficient transcription to generate full genomic HIV transcripts. HIV performs its transcription mainly by using the host cell transcription machinery, with the help of its own master transactivator protein, transactivator of transcription (Tat) . In order to generate complete HIV genomic transcripts, transcription requires successful progression through both the initiation and elongation phases (Fig. 1) . In a recent publication, we have revealed some of the underlying molecular mechanisms that cocaine utilizes to promote both the initiation and elongation phases of HIV transcription in order to enhance the overall rate of HIV gene expression ( (Sahu et al. 2015) Fig. 2 ).
HIV transcriptional initiation
The initiation phase of HIV transcription involves the binding of transcription factors such as SP1, TATA-box-binding protein (TBP), and TBP-associated factors (TAFs) which are recruited to the core long terminal repeats (LTRs) promoter, an essential component sufficient to sustain basal transcription. HIV LTR core promoter consists of TATA box, initiator sequence, and three SP1-binding sites (Ross et al. 1991; Jones et al. 1986; Olsen and Rosen 1992; Rittner et al. 1995; Garcia et al. 1989) . However, efficient initiation of HIV transcription occurs only after the binding of transcriptional activators, primarily nuclear factor kappa-light-chain-enhancer of activated B cells (NF-ĸB), NF-AT, AP-1, and STAT5 to the enhancer sequences of HIV LTR (Nabel and Baltimore 1987; Kinoshita et al. 1997; Selliah et al. 2006; Yang et al. 1999) . These factors, after binding to HIV LTR, promote efficient HIV transcription mainly by recruiting histone acetyltransferases (HATs) and through cooperation with SP1 proteins (Perkins et al. 1993; Gerritsen et al. 1997; Garcia-Rodriguez and Rao 1998; Alcami et al. 1995; Bosque and Planelles 2008) (Fig. 1 ).
Cocaine and HIV transcriptional initiation
The role of cocaine in promoting HIV replication is well established. However, very little is known about the involved molecular mechanisms that cocaine utilizes to enhance HIV gene expression. Recently, we have investigated some of the molecular mechanisms that are modulated by cocaine in order to enhance HIV transcription (Sahu et al. 2015) .
NF-ĸB plays a critical role during HIV transcription
The NF-ĸB/Rel proteins are transcription factors that induce the expression of several cellular genes. Many of these genes regulate host immunity and inflammatory responses (Ghosh et al. 1998; Baldwin 1996) . Transcription factor NF-ĸB consists of either homo-or heterodimers of five related proteins, p65 (Rel A), Rel B, c-Rel, p50/p105 (NF-ĸB), and p52/p100 (NF-ĸB2) (Hayden and Ghosh 2004) . Of these, one of the best-characterized and functionally most active NF-ĸB proteins is the heterodimer which comprises of Rel A (p65) and p50, which is widely expressed and heavily involved in NF-ĸB-regulated transactivation (Nath et al. 2001; Schmitz and Baeuerle 1991) . In its inactive state, the NF-ĸB complexes are sequestered in the cytoplasm through their interaction with inhibitor of ĸB (IĸB) proteins (Hayden and Ghosh 2004; Sobhian et al. 2010) . However, upon cell activation through a wide array of stimuli, serine residues 32 and 36 of IĸB become phosphorylated by several kinases, including the IĸB kinase (IKK) complex, which is composed of IKKα, IKKβ, and IKKγ (Hayden and Ghosh 2004; Brown et al. 1995; Bonizzi et al. 2004; Bonizzi and Karin 2004) , and ribosomal S6 kinase1 (RSK1). This event induces the ubiquitination of IĸB at lysine residues 21 and 22 and leads to the 26S proteasome degradation. Due to the dissociation of IĸB, the nuclear localization signal (NLS) of NF-ĸB proteins becomes exposed, and consequently, NF-ĸB translocates into the nucleus (Brown et al. 1995; Kerr et al. 1991) . Once in the nucleus, NF-ĸB binds to the cognate binding sites at the promoter and enhancer regions of the The CDK9 subunit of P-TEFb subsequently catalyzes the phosphorylation of negative elongation factors DSIF and NELF, which leads to either their dissociation from LTR or reverses their function from negative to positive elongation factor. CDK9 also catalyzes the phosphorylation of CTD of RNAPII, primarily at serine 2 residues. This event makes RNAPII highly processive or transcription elongation proficient that result in the generation of complete and properly processed HIV transcripts genes and activates their transcription including the HIV LTR enhancer region (Fig. 1) . The HIV enhancer region is one of the best studied elements which usually contains two functional NF-kB-binding motifs (Nabel and Baltimore 1987; Perkins et al. 1993 ).
Cocaine accelerates HIV transcriptional initiation by both activating and enhancing the functional activity of NF-kB
Several groups including ours have demonstrated that cocaine promotes both the activation of NF-ĸB and HIV replication (Sahu et al. 2015; Ang et al. 2001; Hou et al. 1996; Yao et al. 2010; Dhillon et al. 2007) . To extend those studies further, using monocytic cell lines (THP1 and U937) and primary monocyte-derived macrophages (MDMs) (Sahu et al. 2015) , we found that during both acute (one time) and chronic (multiple time for 3 days) treatment, cocaine efficiently activates NF-ĸB. Interestingly, cocaine not only promotes the activation (nuclear translocation) of NF-ĸB but also enhances the functional activity of NF-ĸB by augmenting the ability of NF-ĸB to interact with histone acetyltransferases (HATs) (detailed below and Fig. 2 ). Cocaine-induced NF-ĸB activation is primarily mediated via RSK1 activation, instead of IKKβ, a kinase specifically activated by TNF-α, which is one of the strongest and most specific activator of NF-ĸB (Sahu et al. 2015; Ghosh et al. 1998; Ghosh and Hayden 2008) . RSK1 is a downstream kinase of the extracellular signal-regulated kinase (ERK) pathway, one of the main pathways through which cocaine exerts many of its effects (Valjent et al. 2000 (Valjent et al. , 2004 Berhow et al. 1996) . Cocaine-activated RSK1 primarily phosphorylates IĸBβ at Ser19 and Ser23 (our unpublished data), instead of IĸBα, which is mainly phosphorylated by IKKβ (Ghoda et al. 1997) . NF-ĸB activation in addition to activating the transcription of other genes, promotes the transcription of its own inhibitor IĸBα. The newly formed IĸBα interacts with NF-ĸB and takes it to the cytoplasm and thus negatively regulates expression of NF-ĸB-dependent genes. Interestingly, unlike IĸBα, the IĸBβ promoter does not have NF-κB-binding sites. Consequently, cocaine-induced NF-ĸB activation does not directly lead to the synthesis of its inhibitor. Hence, RSK1-induced NF-κB activation lasts longer and eventually contributes to the persistence of a cocaine effect (our unpublished data and (Thompson et al. 1995) ).
In addition to the activation of NF-κB, cocaine exposure enhances the functional activity of NF-ĸB primarily by activating mitogen-and stress-activated kinase 1 (MSK1). MSK1 is another kinase that becomes activated upon the stimulation of the MAPK/ERK cascade (Lu et al. 2006; Zhai et al. 2008 ). Cocaine treatment results in the activation and recruitment of NF-κB and MSK1 at HIV LTR. MSK1 subsequently catalyzes the phosphorylation of NF-κB at its serine residue 276. Phosphorylation of NF-κB at the 276th serine residue enhances the functional capability of NF-κB by augmenting the interaction of NF-κB with HATs. HATs such as p300 in turn catalyze the acetylation of core histones (mainly H3 and H4) at HIV LTR and facilitate the establishment of transcriptionally active chromatin structures, which boost the access of transcription machinery to HIV LTR and thus facilitate the initiation phase of HIV transcription. MSK1 in addition to phosphorylating NF-κB catalyzes the phosphorylation of histone H3 at serine 10 (H3S10). Phosphorylated histone H3 at the 10th residue contributes to the establishment of transcriptionally active chromatin structure at HIV LTR. Moreover, phosphorylated H3S10 also facilitates the recruitment of P-TEFb at HIV LTR through a mechanism that is not yet fully defined, usually with the help of BRD proteins which bind specifically to acetylated histones through their bromo domain. P-TEFb, an established elongation factor, subsequently catalyzes the phosphorylation of several proteins, including RNA polymerase II (RNAPII) and negative elongation factors. These modifications enhance the processivity of RNAPII and nullify the impact of negative elongation factors and thus promote the elongation phase of HIV transcription MSK1 subsequently phosphorylates the p65 subunit of NF-ĸB at serine residue 276 (p65S276). This posttranslational modification boosts the interaction of NF-ĸB with HATs (Sahu et al. 2015; Zhong et al. 2002; Vermeulen et al. 2003; Perkins et al. 1997) . Enhanced interaction translates into higher recruitment of HATs at HIV LTR through NF-ĸB binding to its consensus-binding sequences at HIV LTR. HATs in turn acetylate the core histones, which reduce the electrostatic interactions between the histones and DNA. Less interaction between DNA and histones results in more relaxed/open chromatin structures near the LTR promoter. These relaxed transcriptionally active chromatin structures consequently further promote access to all the remaining components of the transcription machinery (holo-transcription machinery) and even augment the overall flow of transcription machinery at the HIV LTR promoter. These events eventually enhance the rate of transcriptional initiation from the LTR promoter (Sahu et al. 2015) .
HIV transcriptional elongation
The efficiency of the elongation phase of HIV transcription is predominantly dependent on the HIV protein Tat. However, prior to sufficient Tat protein generation, the elongation phase of HIV transcription proceeds very slowly. The Tat-independent inefficient phase of HIV transcription is primarily attributed to the presence of two elongation inhibitory factors, negative elongation factor (NELF) and DRB sensitivity-inducing factor (DSIF) at HIV LTR (for recent reviews, refer to (Nechaev and Adelman 2011; Cho et al. 2010; Tyagi and Bukrinsky 2012; Mbonye and Karn 2014; Taube and Peterlin 2013; Jadlowsky et al. 2014) ). In addition to restricting HIV transcription, these negative elongation factors ubiquitously inhibit the transcription of numerous cellular genes. Moreover, in brain-resident macrophages, microglia, HIV transcription is further repressed by the chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2 (CTIP2), an inhibitor of positive transcription elongation factor b (P-TEFb) predominantly expressed in microglial cells (Marban et al. 2005 (Marban et al. , 2007 Eilebrecht et al. 2014 ). In addition to using the cellular machinery to relieve the restriction posed by NELF and DSIF, HIV utilizes its specialized protein, Tat, to facilitate this function. In the absence of Tat, most of the HIV transcripts halt at approximately 60 nucleotides due to the presence of NELF and DSIF along with non-processive or elongation-defective RNA polymerase II (RNAPII) at HIV LTR. Once Tat is synthesized and accumulated in the cell beyond a certain threshold, Tat positively feedbacks the entire system. To perform its functions, Tat requires binding to an RNA stem loop structure called the transactivation response (TAR) element which is present at the 5′ extremity of all HIV transcripts. Along with it, Tat brings the P-TEFb protein, which mediates most of the transcriptional functions of Tat (Karn 1999; Herrmann and Rice 1995; Peterlin and Price 2006) . The cyclin-dependent kinase 9 (CDK9) subunit of P-TEFb subsequently hyper-phosphorylates the C-terminal domain (CTD) of RNAPII and converts the pausing RNAPII into a processive or elongation-proficient polymerase (Parada and Roeder 1996; Kim et al. 2002) . Besides RNAPII, P-TEFb also phosphorylates inhibitory factors DSIF and NELF. These modifications either dissociate the negative factors or convert them into a positive transcription factor (Fujinaga et al. 2004; Bourgeois et al. 2002; Ivanov et al. 2000) . P-TEFb recruitment at LTR is also essential to reactivate latent provirus in primary T cells (Tyagi et al. 2010; Budhiraja et al. 2013 ). Besides recruiting P-TEFb, Tat also brings additional elongation factors, such as ELL2, AFF4, ENL, and AF9; together, they form a super elongation complex (SEC) at HIV-1 LTR ( Fig. 1) (Sobhian et al. 2010; He et al. 2011; Chou et al. 2013 ). ELL2 and the scaffold protein AFF4 have been shown to be the critical components of the SEC, as their knockdown or removal strongly inhibits Tat-dependent LTR-driven reporter gene expression (Sobhian et al. 2010; He et al. 2010) . The binding of AFF4 in the presence of Tat modulates the Tat-TAR recognition motif of cyclin T1 and increases the affinity of Tat-P-TEFb complex for TAR several folds (Schulze-Gahmen et al. 2014; Gu et al. 2014) . The enhanced rate of HIV transcription results in generating more Tat protein, and higher Tat levels further accelerate HIV transcription. Hence, HIV transcription enters into the fast Tat-dependent phase that eventually accelerates HIV transcription several hundred fold (Karn 1999; Taube et al. 1999) . HIV transcription thus differs from the normal transcription of cellular genes as it is autoregulated by the Tat protein. These events subsequently relieve all restrictions to HIV transcription, and consequently, efficient HIV transcription enhances the rate of generation of full-length mature transcripts. This includes the production of unspliced HIV genomic transcripts which get packaged and lead to the generation of new viral particles, indicated as an enhanced rate of HIV replication (Pomerantz et al. 1990; Kim et al. 1989 ).
Cocaine and HIV transcriptional elongation
It is well known that cocaine augments the rate of HIV replication and that cocaine is able to induce the generation of full-length HIV genomic transcripts. As aforementioned, in order to generate the full genomic transcript, HIV transcription has to pass through both the initiation and elongation phases of transcription. Thus, in addition to NF-ĸB activation, this implies that cocaine activates P-TEFb, an essential factor required for the elongation phase of HIV transcription (Fig. 1) .
Cocaine promotes HIV transcriptional elongation primarily by activating MSK1
Cocaine activates MSK1 which, besides catalyzing the phosphorylation of the p65 subunit of NF-ĸB at serine 276, also catalyzes the phosphorylation of histone H3 at serine 10 (P-H3S10) at the HIV LTR promoter (Sahu et al. 2015) . Notably, cocaine also enhances the phosphorylation of p65 and of histone H3 locally at HIV LTR by augmenting the recruitment of MSK1 at LTR (Sahu et al. 2015) . Comparable observations have also been reported for cellular promoters following cocaine exposure (Soloaga et al. 2003) . Although several other enzymes besides MSK1 are known to catalyze H3S10 phosphorylation, the predominant role of MSK1 during cocaine exposure has been well established (Nestler 2012; Walker et al. 2014; Brami-Cherrier et al. 2009 ). P-H3S10 is a euchromatic mark which facilitates the establishment of transcriptionally active chromatin structure (Soloaga et al. 2003; Wei et al. 1998 ). Accordingly, MSK1-induced H3S10 phosphorylation promotes the establishment of transcriptionally active chromatin structures at HIV-1 LTR following cocaine treatment (Sahu et al. 2015) .
In addition to facilitating the establishment of transcriptionally active chromatin structures, P-H3S10 promotes the recruitment of P-TEFb to HIV LTR analogous to other gene promoters (Sahu et al. 2015; Ivaldi et al. 2007; Hu et al. 2014 ). As noted above, P-TEFb plays an essential role in supporting the elongation phase of HIV-1 transcription by catalyzing several abovementioned phosphorylation events (detailed in the BHIV transcriptional elongation^section, Figs. 1 and 2) (Peterlin and Price 2006; Parada and Roeder 1996; Kim et al. 2002; Fujinaga et al. 2004; Bourgeois et al. 2002; Ivanov et al. 2000; Wei et al. 1998; Karn 2011) . The resultant, complete unspliced HIV transcripts are then packaged and lead to the generation of new viral particles which are represented as enhanced HIV replication. Thus, cocaine boosts HIV-1 gene expression by inducing both the initiation and elongation phases of HIV-1 transcription.
Role of epigenetics in controlling HIV transcription and latency
Like other retroviruses, HIV integrates itself into the host cell genome, preferentially within the intronic regions of actively transcribing genes. This inclination is due to the selective binding preference of lens epithelium-derived growth factor (LEDGF), a protein that plays an important role during HIV i n t e g r a
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transcriptionally active open chromatin structures (Schroder et al. 2002; Han et al. 2004; Meehan et al. 2009; Lewinski et al. 2006; Vatakis et al. 2009; Brady et al. 2009 ). Analogous to cellular genes, the expression of integrated HIV genome is facilitated by the formation of transcriptionally active chromatin structures around the LTR promoter (Verdin et al. 1993) .
The chromatin structures are characterized by their fundamental subunits, nucleosomes. A nucleosome comprises of an octamer, a pair of four core histones (H3, H4, H2A, and H2B), which are wrapped around by 147 base pairs of DNA. These core histones undergo various kinds of post-translational modifications such as acetylation, methylation (mono-, di-, or tri-methylation), SOMOylation, phosphorylation, and ubiquitinylation (Kouzarides 2007) . These modifications are called epigenetic modifications, as they can be passed through to the next generation. These epigenetic modifications eventually define the specific nature of the chromatin structures. Chromatin structures, especially in the vicinity of the promoter region of a gene, regulate its expression. Thus, the type and amount of epigenetic modifications harbored play a decisive role in defining specific chromatin structure and subsequent regulation of gene expression (Wolffe 1994; Narlikar et al. 2002; Felsenfeld and Groudine 2003) . The open or relaxed chromatin structure, which promotes access to the transcription machinery at the promoter region of a gene, is called transcriptionally active or euchromatin structure. On the other hand, the closed or compact chromatin structure, which inhibits the access of transcription machinery to the promoter region of a gene is called transcriptionally repressive or heterochromatin structure (Kouzarides 2007; Narlikar et al. 2002) .
The HIV LTR promoter is precisely flanked by two wellplaced nucleosomes, independent of the site of integration in the cellular genome The nucleosome-0 (Nuc-0) is located upstream of the LTR promoter, and nucleosome-1 (Nuc-1) is assembled downstream from the LTR promoter ( (Verdin et al. 1993; Verdin 1991) , Fig. 1 ). The epigenetic modifications of these two nucleosomes (Nuc-0 and Nuc-1) play a major role in defining the overall chromatin structure near LTR promoter and consequently controlling the initiation of HIV transcription (Verdin et al. 1993; Jordan et al. 2001 Jordan et al. , 2003 .
The chromatin structures at HIV LTR are remodeled mainly by two kinds of protein complexes. One of these protein complexes modifies chromatin structures by inducing various post-translational epigenetic modifications at the N-terminal tails of histones. It is noteworthy that the binding of the basal transcription factors to the chromatin-free promoter region of LTR is not hindered by the surrounding higher order epigenetic nucleosomal structures. The major chromatin reorganization at HIV LTR begins after the binding of factors, such as NF-κB to the enhancer region of the HIV LTR. NF-κ B subsequently recruits histone acetyltransferases (HATs); HATs in turn greatly induce remodeling of the surrounding chromatin structures at HIV LTR. Moreover, Tat also brings HAT-containing complexes at HIV LTR. Together, recruited HATs successively promote the establishment of transcriptionally active chromatin structures at HIV LTR, which, in turn, support Tat-mediated induction of HIV transcription (Marzio et al. 1998; Benkirane et al. 1998; Hottiger and Nabel 1998; Ott et al. 1999) . The second group of chromatin-modifying complexes uses energy to change the structures of nucleosomes in order to open up or relax nucleosomal structure. The SWItch/Sucrose NonFermentable (SWI/SNF) is one of such complexes that changes the location and reorganization of nucleosomes via an ATPdependent mechanism. The SWI/SNF-remodeling complexes facilitate the opening of the nucleosomal structures and promote access of the LTR promoter to transcription factors (for detail, please refer to (Hargreaves and Crabtree 2011; Liu et al. 2011; Rafati et al. 2011; Hakre et al. 2011; Agbottah et al. 2006; Van Duyne et al. 2011; Mahmoudi et al. 2006; Henderson et al. 2004; Treand et al. 2006) ). These events eventually accelerate the overall rate of HIV transcription.
In addition to the post-translational modification of nucleosomal histones, other epigenetic modifications, such as DNA methylation at the CpG islands flanking the transcription start site, have also been implicated in regulating the HIV gene expression (Kauder et al. 2009; Blazkova et al. 2009; Chavez et al. 2011) . Even the role of certain non-coding RNA, primarily microRNA (miRNA), has been implicated in HIV transcription and latency (Suzuki et al. 2015; Budhiraja and Rice 2013) . The miRNAs are singlestranded small RNA molecules that bind to specific complementary sequences on the target mRNA and usually inhibit its translation. However, miRNA binding occasionally also results in the degradation of specific mRNA (Bartel 2004) . The vital role of viral and cellular miRNAs has been demonstrated in regulating HIV gene expression and latency. In particular, cellular miR-28, miR-125b, miR-150, miR-223, and miR-382, which are enriched in metabolically silent, resting CD4+ T lymphocytes, suppress HIV translation by targeting its mRNA (Pomerantz et al. 1991; Lassen et al. 2006; Huang et al. 2007) . A number of recent papers provide further details of miRNAmediated regulation of HIV latency (Huang et al. 2007; Yeung et al. 2007; Bennasser et al. 2007; Triboulet and Benkirane 2007; Sun and Rossi 2011; Kumar and Jeang 2008; Sung and Rice 2009; Corbeau 2008; Narayanan et al. 2011; Klase et al. 2007 ). Cocaine has been reported to up-and downregulate multiple miRNAs, such as the upregulation of miR-181a and downregulation of miR-124 and let-7d (Chandrasekar and Dreyer 2009; Sartor et al. 2012) . Accordingly, cocaine has been shown to enhance HIV-1 replication in CD4+ T cells by downregulating miR-125b (Mantri et al. 2012) . Therefore, innovative methodologies designed to manipulate the action of involved miRNAs could be proved useful in regulating HIV gene expression, latency, and modulating impact of drugs of abuse.
It is worthy to note that most of the enzymes that catalyze epigenetic modifications do no bind directly to DNA. As a result, the epigenetic enzymes must be recruited to HIV LTR by a variety of DNA-binding proteins. HIV transcriptional repressors such as CBF-1, YY1/LSF1, P50 homodimer, AP4, CTIP2, and thyroid hormone receptor recruit chromatin-modifying enzymes to the LTR along with several other proteins as multiprotein complexes, which subsequently induce transcriptionally repressive, heterochromatin structures, at HIV LTR (Marban et al. 2007; Tyagi and Karn 2007; Coull et al. 2000; Hsia and Shi 2002; Williams et al. 2006; Imai and Okamoto 2006) . We have demonstrated that CBF-1-induced repressive chromatin structures play an important role in restricting HIV transcription and promote HIV latency in primary CD4+ T cells (Tyagi et al. 2010 ). The role of repressive epigenetic modifications in restricting HIV transcription during latency is quite evident due to the fact that their removal or inhibition leads to the reactivation of latent proviruses (Tyagi and Bukrinsky 2012; Karn 2011, 2014; Hakre et al. 2011; Choudhary et al. 2011; Margolis 2011) .
It has been well established that epigenetic modifications play an important role in regulating HIV transcription. However, the precise nature of the underlying molecular mechanisms that regulate these specific epigenetic changes at HIV LTR is still not fully defined. Understanding the precise role of epigenetic modifications and the mechanisms involved could be of therapeutic importance in reactivating latent proviruses which are mainly silent due to the lack of productive HIV transcription. Thus, there is an enormous potential for drugs that could manipulate chromatin structures at HIV LTR and regulate HIV gene expression. Different drugs of abuse including cocaine also induce chromatin structure reorganization at numerous cellular genes and HIV LTR (detailed in the following section). However, a huge body of work is still required to precisely characterize and define the vital role of epigenetic modifications induced by cocaine. Thus, there is a pressing need to examine the molecular mechanisms involved during interactions between the virus and drugs of abuse at the gene expression level to determine how they may be affecting HIV replication.
Impact of cocaine-induced epigenetic changes on HIV transcription
The important role for cocaine-induced epigenetic modifications in altering the expression of several genes in the central nervous system has been clearly demonstrated (Renthal et al. 2007; Levine et al. 2005; Kumar et al. 2005) . Different types and levels of epigenetic modifications of the nucleosomal core histones eventually define the nature of the chromatin structure at and around gene promoters. Transcriptionally active, open/euchromatin structures facilitates transcription, whereas transcriptionally repressive, closed/heterochromatin structures suppress transcription by inhibiting the access of transcription machinery to the genetic elements responsible for transcription. Moreover, the long-lasting effects of different stimuli on the brain, including cocaine-induced plasticity which can persist even after its removal, can be better explained by the concept of relatively stable specific epigenetic modifications and the resulting persistent long-term expression of selected CNS genes even after the removal of stimuli. Epigenetic dysregulations and the resultant changes in the responsible genes have been implicated in several neuronal dysfunctions, including Huntington's disease, Friedreich ataxia, and Rett syndrome (Brami-Cherrier et al. 2009; Tsankova et al. 2007 ). These observations further strengthen the concept that cocaine-induced epigenetic modifications may be involved in the exaggeration of neurodegeneration seen in HIV-infected drug abusers. The better understanding of these mechanisms will reveal new drug targets and open up new avenue for better pharmaceutical interventions in drug addict HIV patients.
Cocaine-induced histone modifications at HIV LTR
Interestingly, the mode of cocaine exposure (acute or chronic) also regulates the activation and duration of gene expression by inducing a selective set of epigenetic modifications (Kumar et al. 2005; Maze and Nestler 2011; Renthal et al. 2009; Nestler 2008, 2009; Feng and Nestler 2013; Nestler 2014) . Genome-wide Chromatin Immunoprecipitation (ChIP) analysis following cocaine exposure results in both the subtle and persistent induction of genes due to selective histone H3 and H4 acetylation (Kumar et al. 2005; Renthal et al. 2009; Tsankova et al. 2004) . Interestingly, on a number of genes, enhanced acetylation of histone H3 was found to be associated with chronic cocaine treatment, while histone H4 hyper-acetylation was found to occur specifically during acute cocaine treatment. However, a lot of genes did not follow this pattern. These facts further validate that the histone code for gene regulation is a complex phenomenon. Histone acetylation, although a vital epigenetic modification, is still not sufficient to dictate the expression of a gene, and the contribution of different epigenetic modifications on a particular gene defines its eventual expression (Kumar et al. 2005; Nestler 2008, 2009; Nestler 2014; Tsankova et al. 2004; Brami-Cherrier et al. 2005) . Another important finding from these analyses was that cocaine usually promotes gene expression by inducing both phosphorylation and acetylation of core histones. However, cocaine has also been found to suppress a small subset of genes by inducing histone H3 methylation at lysine 9 (Kouzarides 2007; Chiappelli et al. 2008; Shapshak et al. 2006 Shapshak et al. , 2008 Black et al. 2006) . To further complicate this scenario, recent studies have confirmed that cocaine specifically inhibits class II histone deacetylases (HDACs), mainly HDAC-4 and HDAC-5, but activates class III HDACs, NAD-dependent deacetylase sirtuin 1 (SIRT1), and SIRT2 (Renthal et al. 2007 Maze and Nestler 2011) . Moreover, cocaine also promotes gene expression by downregulating histone methyltransferases, including G9a and G9a-like protein (GLP). These enzymes catalyze the methylation of histone H3 at lysine 9, a transcriptionally repressive heterochromatic mark (Maze et al. 2010 ). These observations suggest that besides histones, the post-translational modification of several non-histone proteins by these enzymes is responsible for deciding the expression of cellular genes following cocaine exposure.
In the context of HIV infection, we have investigated the role of cocaine-induced epigenetic modifications on HIV gene expression (Sahu et al. 2015 ). Our results demonstrate that cocaine treatment greatly enhances the recruitment of histone acetyltransferase (HAT), p300, at HIV LTR and leads to the dissociation of histone deacetylase, HDAC1 and HDAC3, from LTR. These events result in the hyper-acetylation of core histones both H3 and H4 (Sahu et al. 2015) . Thus, we found that cocaine-induced epigenetic modifications at HIV LTR do not follow any strict core histone acetylation pattern. In addition to histone acetylation, cocaine treatment induces phosphorylation of histone H3 at serine 10 (p-H3S10). Acetylation and phosphorylation of core histones partially neutralizes the positive ionic charge of histones, and thus, both of these epigenetic modifications contribute to the establishment of relaxed transcription-promoting euchromatin structures at HIV LTR. Interestingly, upon cocaine treatment, we also observed the loss of heterochromatic epigenetic modifications such as trimethylation of histone H3 at lysine 9 (H3K9me 3 ) and lysine 27 (H3K27me 3 ) from HIV LTR. As indicated in Fig. 2 , our results demonstrated that cocaine exposure converts the transcriptionally repressive heterochromatin structures into transcriptionally active euchromatic structures at HIV LTR (Sahu et al. 2015) . Accordingly, we found higher recruitment of RNA polymerase II at HIV LTR, further validating the fact that the euchromatin structure promotes the access to transcription machinery at gene promoters and facilitates HIV transcription.
Therapeutic implications to counter cocaine impact
Development of HAART regimens that penetrate better blood brain barrier (BBB) Current HAART regimens may result in the establishment of several anatomical sanctuary sites such as the CNS because of poor tissue penetration. In these sanctuary sites, a perpetual low level of viral replication has been documented by several studies (Cory et al. 2013; Palmer et al. 2011) . Eradication of HIV from sanctuary sites holds the key to HIV cure. Cocaine use further burdens HIV patients by accelerating ongoing HIV replication, primarily in the CNS of HIV patients (Nath et al. 2001; Parikh et al. 2014; Ioannidis et al. 2000; Chiasson et al. 1990; Anthony et al. 1991) . Hence, better penetrating HAART regimens into HIV sanctuary sites, including the CNS, will improve cognitive performance, as has been demonstrated during HAART intensification with better BBB-crossing HAART regimens (Smurzynski et al. 2011; Rappaport and Volsky 2015) .
Inclusion of drugs in HAART regimens that restrict HIV transcription
While HAART efficiently restricts the HIV replication and infection of new cells, it is unable to prevent the transcription of viral proteins. The viral proteins that are produced induce several side effects, especially chronic inflammation, by entering and interacting with cells and cellular proteins. The CNS is particularly sensitive to the inflammation induced by viral proteins, such as gp120, Tat, and Nef. The produced inflammatory cytokines and cytotoxic products secreted by brain cells, especially microglia and perivascular macrophages and to a lesser extent astrocytes, subsequently induce neuropathy Lipton and Gendelman 1995) . Therefore, it implies that cocainemediated enhanced HIV transcription elevates the levels of viral proteins even in the presence of HAART regimens and contributes to chronic brain inflammation and deterioration of CNS functioning (Sahu et al. 2015) . Although some HAART agents have shown clear benefit in protecting against neurocognitive impairments, yet higher penetration of HAART drugs may be associated with neurotoxicity (Letendre et al. 2008; Robertson et al. 2010; Marra et al. 2009; Perez-Valero et al. 2013) . Hence, there is an urgent need to perform systematic studies to settle these confounding results.
Conclusion and perspectives
Studies of the effects of cocaine on HIV gene expression are still in their infancy. Our work was the first to describe the salient underlying molecular mechanisms that cocaine utilizes in order to enhance HIV transcription. The transcription factors discussed above are just a few of many that affect HIV gene expression. The main goal of future research is to obtain a comprehensive view of the transcription factors induced by cocaine and their effect on the initiation and elongation phase of expression of relevant genes, especially those that affect HIV gene expression and brain function.
We found that cocaine induces the chromatin remodeling at HIV LTR via MSK1 and histone H3 phosphorylation. Similar epigenetic modifications at various gene promoters, especially in brain cells, have been implicated in some of the long-lasting behavioral consequences of cocaine. In order to better understand the cocaine-induced epigenetic modifications at HIV LTR, it will be necessary to involve high-throughput approaches, such as ChIP-Seq, to identify numerous other post-translational modifications in both histone and nonhistone proteins.
There remains a huge body of work necessary to precisely characterize and define the vital role of epigenetic modifications induced by cocaine. There is a pressing need to examine the molecular mechanisms that are involved during the interactions between the virus and drugs of abuse at the level of gene expression in order to determine how they may be affecting HIV replication. A better understanding of these mechanisms may reveal new drug targets and open up new avenues for better pharmaceutical interventions in HIV-infected drug abusers.
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